Conclusions: The pleural fluid to serum cholinesterase ratio is the most accurate criterion for separating pleural transudates and exudates. If further studies confirm our results, the cholinesterase ratio could be used as the first step in the diagnosis of pleural effusions.
primary malignancy was known, other causes of effusions were excluded, and the evolution was radiologically and clinically compatible with malignant pleural effusion. The following were excluded in the analysis: effusions of undetermined origin, effusions with more than one possible cause, empyemas, and hemothorax.
The criteria analyzed for the separation of transudates and exudates were as follows: the criteria of Light et al,' exudate x,vhen pleural fluid to serum protein ratio was greater than 0.5, pleural fluid LDH greater than two thirds of the upper normal serum limit, or pleural fluid to ser-um LDH ratio greater than 0.6; pleural fluid cholesterol; pleural fluid to serum cholesterol ratio; pleural fluid cholinesterase; and the pleural fluid to serum cholinesterase ratio. 
RESULTS
One hundred ninety-three patients with pleural effusion were evaluated. Forty (20.7%) patients were excluded: 32 because no possible cause was definitely diagnosed or more than 1 cause was present, 5 due to the diagnosis of empyema, 1 hemothorax, and 2 because it was not possible to determine all the biochemical parameters.
Of the remaining 153 patients finally studied, 100 were men, and 53 were women. The average (SD) age was 58 (19) years. Thirty-five (22.9%) were defined as having transudates and 118 (77.1%) as exudates. The diagnoses are listed in Table 1 . Among the 60 malignant pleural effusions, 35 (58.3%) were diagnosed by proved malignancy in pleural fluid cytologic study, pleural needle biopsy specimen, or thoracoscopic findings.
The number and percentage of pleural effusions misclassified for each diagnosis and every parameter studied are detailed in Table 2 (transudates) and Table 3 (exudates).
Using the criteria of Light et al,1 12 effusions were incorrectly classified (7.8%). Nine were transudates (25.7% of the 35 transudates) and 3 were exudates (2.5% of the 118 exudates). One of the two malignant effusions misclassified had proved malignancy in pleural fluid cytologic study.
The pleural fluid cholesterol level was, on average, 28 (15) mg/dL in transudates and 88 (31) mg/dL in exudates (p<0.001). The best cutoff value for the exudate in this series was 50 mg/dL or greater. With this criterion, 12 effusions (7.8%) were misclassified, 1 transudate (2.8%) and 11 exudates (9.3%). Of the six malignant exudates falsely classified by this criterion, three had malignant cells in pleural fluid.
The pleural fluid to serum cholesterol ratio was, on average, 0.15 (0.07) in transudates and 0.51 (0.14) in exudates (p<0.001). Using a dividing line of 0.30 or more for the exudate, 10 effusions (6.5%) were falsely classified. Ofthese, 1 was transudate (2.8%) and 9 were exudates (7.6%). With this ratio, six malignant exudates were misclassified, four of them with evidence of pleural involvement.
The level of the pleural fluid cholinesterase was different for each hospital. In hospital A, the mean was 834 (440) U/L in transudates and 3,121 (1,144) U/L in exudates, and in hospital B, it was 1,401 (1,089) U/L and 4,638 (2,071) U/L, respectively. Differences between transudates and exudates were statistically significant (p<0.001). The best value for separating trans- The mean of the pleural fluid to serum cholinesterase ratio was 0.16 (0.06) in transudates and 0.49 (0.15) in exudates (p<0.001). Using a cutoff level of more than 0.23 for the exudate, 151 of the 153 effusions (98.7%) were correctly classified. The 2 effusions misclassified were transudates due to liver cirrhosis with a cholinesterase ratio of 0.27 and 0.35. These cases were correctly classified as transudates by all the other criteria. The higher value of the remaining transudative effusions was 0.22. In the exudative effusions, the lower value was 0.24. Figure 1 details the value of the ratio in transudates (due to congestive heart failure and other transudates) and exudates (malignant and others).
The percentage of effusions misclassified, summarized in Table 4 , was significantly lower (p<0.05) with the cholinesterase ratio when compared with all the other criteria.
When the 25 patients without pleural cytologic or histologic evidence of malignancy were excluded from the 60 patients with malignant pleurisy, the yield ofthe different parameters in exudates does not change significantly. In this group of 93 exudates, the percentage The pleural fluid cholinesterase level shows poorer results than the cholinesterase ratio, but similar to the other criteria. This finding is not surprising because cholinesterase is synthesized in the liver and the levels can be influenced by different disorders. These include acute hepatitis, cirrhosis, acute infections, pulmonary embolism, chronic renal disease, and after surgical procedures.8
For segregating transudates from exudates, the cri- composition of the exudative groups can lead to differences in the accuracy of this criterion, because in tuberculous exudates, the cholesterol criterion works better than in malignant effusions.12
In addition to cholesterol, other parameters have been proposed for separating pleural transudates and exudates. In a study of 46 pleural effusions, Meisel et al4 evaluated the usefulness of the pleural fluid to serum bilirubin concentration ratio. Tahaoglu et a16 described that, on average, the level of alkaline phosphatase was lower in the transudates with respect to exudates, but the number of the effusions correctly or incorrectly classified by this criterion was not detalied.
In our study, we included only patients with clinical indication for diagnostic thoracentesis. Thus, our sample reliably represents the patient population who needs a method for distinguishing between transudates and exudates. Moreover, we have been especially careful in excluding the cases with more than one possible origin of the effusion (for example, patients with heart failure and pneumonia or malignancy). These precautions allow us to state that the pleural fluid to serum cholinesterase ratio is the most useful criterion for the separation oftransudates and exudates when a diagnostic thoracentesis is performed. Only some transudative effusions due to liver chirrosis might be classified incorrectly as exudate. Usually, these effusions can be diagnosed without difficulty, but it is logical to use this criterion with care in patients with liver cirrhosis and pleural effusion. In these patients, the other parameters studied classified the effusions correctly. Thus, the simultaneous use of another criterion with the cholinesterase ratio can contribute to the diagnostic approach used in these cases.
We included as malignant effusions a group of patients without cytologic or histologic confirmation of pleural involvement. We assume this etiology because it is well known that the pleural fluid cytologic study is positive only in 54 to 71% of patients with malignant effusions, 15-17 and adding pleural biopsy specimens, the yield increases slightly.1 Nevertheless, ifthis group is excluded from the analysis, the results of the different criteria do not change significantly.
The initial classification of the pleural effusions in transudates and exudates seems to be unquestionably necessary. 18 The results of our study show that the Clinical Investigations .I L I pleural fluid to serum cholinesterase ratio is the most accurate parameter for the separation of transudates and exudates. Iffurther studies confirm our results, the cholinesterase ratio could be used as the first step in the diagnostic study of a pleural effusion.
